BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26767511)

  • 1. Enrichment of immunoregulatory proteins in the biomolecular corona of nanoparticles within human respiratory tract lining fluid.
    Kumar A; Bicer EM; Morgan AB; Pfeffer PE; Monopoli M; Dawson KA; Eriksson J; Edwards K; Lynham S; Arno M; Behndig AF; Blomberg A; Somers G; Hassall D; Dailey LA; Forbes B; Mudway IS
    Nanomedicine; 2016 May; 12(4):1033-1043. PubMed ID: 26767511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the coronal proteome acquired by particles depositing in the lungs of asthmatic versus healthy humans.
    Kumar A; Bicer EM; Pfeffer P; Monopoli MP; Dawson KA; Eriksson J; Edwards K; Lynham S; Arno M; Behndig AF; Blomberg A; Somers G; Hassall D; Dailey LA; Forbes B; Mudway I
    Nanomedicine; 2017 Nov; 13(8):2517-2521. PubMed ID: 28647590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of Protein Corona on Nanoparticle Affects Different Complement Activation Pathways Mediated by C1q.
    Ding T; Sun J
    Pharm Res; 2019 Dec; 37(1):10. PubMed ID: 31872347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Person-Specific Biomolecular Coronas Modulate Nanoparticle Interactions with Immune Cells in Human Blood.
    Ju Y; Kelly HG; Dagley LF; Reynaldi A; Schlub TE; Spall SK; Bell CA; Cui J; Mitchell AJ; Lin Z; Wheatley AK; Thurecht KJ; Davenport MP; Webb AI; Caruso F; Kent SJ
    ACS Nano; 2020 Nov; 14(11):15723-15737. PubMed ID: 33112593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the human and mouse protein corona profiles of functionalized SiO
    Solorio-Rodríguez A; Escamilla-Rivera V; Uribe-Ramírez M; Chagolla A; Winkler R; García-Cuellar CM; De Vizcaya-Ruiz A
    Nanoscale; 2017 Sep; 9(36):13651-13660. PubMed ID: 28875999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Link between Low-Fouling and Stealth: A Whole Blood Biomolecular Corona and Cellular Association Analysis on Nanoengineered Particles.
    Weiss ACG; Kelly HG; Faria M; Besford QA; Wheatley AK; Ang CS; Crampin EJ; Caruso F; Kent SJ
    ACS Nano; 2019 May; 13(5):4980-4991. PubMed ID: 30998312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What are the biological and therapeutic implications of biomolecule corona formation on the surface of inhaled nanomedicines?
    Kumar A; Forbes B; Mudway I; Bicer EM; Dailey LA
    Nanomedicine (Lond); 2015 Feb; 10(3):343-5. PubMed ID: 25707971
    [No Abstract]   [Full Text] [Related]  

  • 8. Proteomic and Lipidomic Analysis of Nanoparticle Corona upon Contact with Lung Surfactant Reveals Differences in Protein, but Not Lipid Composition.
    Raesch SS; Tenzer S; Storck W; Rurainski A; Selzer D; Ruge CA; Perez-Gil J; Schaefer UF; Lehr CM
    ACS Nano; 2015 Dec; 9(12):11872-85. PubMed ID: 26575243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuning complement activation and pathway through controlled molecular architecture of dextran chains in nanoparticle corona.
    Coty JB; Eleamen Oliveira E; Vauthier C
    Int J Pharm; 2017 Nov; 532(2):769-778. PubMed ID: 28450168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology.
    Tenzer S; Docter D; Kuharev J; Musyanovych A; Fetz V; Hecht R; Schlenk F; Fischer D; Kiouptsi K; Reinhardt C; Landfester K; Schild H; Maskos M; Knauer SK; Stauber RH
    Nat Nanotechnol; 2013 Oct; 8(10):772-81. PubMed ID: 24056901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dispersion of Nanoparticles in Different Media Importantly Determines the Composition of Their Protein Corona.
    Strojan K; Leonardi A; Bregar VB; Križaj I; Svete J; Pavlin M
    PLoS One; 2017; 12(1):e0169552. PubMed ID: 28052135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of nanoparticle mechanical property on protein corona formation.
    Tengjisi ; Hui Y; Fan Y; Zou D; Talbo GH; Yang G; Zhao CX
    J Colloid Interface Sci; 2022 Jan; 606(Pt 2):1737-1744. PubMed ID: 34507167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
    Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
    Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes.
    Tavano R; Gabrielli L; Lubian E; Fedeli C; Visentin S; Polverino De Laureto P; Arrigoni G; Geffner-Smith A; Chen F; Simberg D; Morgese G; Benetti EM; Wu L; Moghimi SM; Mancin F; Papini E
    ACS Nano; 2018 Jun; 12(6):5834-5847. PubMed ID: 29750504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microfluidic Examination of the "Hard" Biomolecular Corona Formed on Engineered Particles in Different Biological Milieu.
    Weiss ACG; Kempe K; Förster S; Caruso F
    Biomacromolecules; 2018 Jul; 19(7):2580-2594. PubMed ID: 29668268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein corona: implications for nanoparticle interactions with pulmonary cells.
    Konduru NV; Molina RM; Swami A; Damiani F; Pyrgiotakis G; Lin P; Andreozzi P; Donaghey TC; Demokritou P; Krol S; Kreyling W; Brain JD
    Part Fibre Toxicol; 2017 Oct; 14(1):42. PubMed ID: 29084556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stealth effect of biomolecular corona on nanoparticle uptake by immune cells.
    Caracciolo G; Palchetti S; Colapicchioni V; Digiacomo L; Pozzi D; Capriotti AL; La Barbera G; Laganà A
    Langmuir; 2015 Oct; 31(39):10764-73. PubMed ID: 26378619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein corona formation in bronchoalveolar fluid enhances diesel exhaust nanoparticle uptake and pro-inflammatory responses in macrophages.
    Shaw CA; Mortimer GM; Deng ZJ; Carter ES; Connell SP; Miller MR; Duffin R; Newby DE; Hadoke PW; Minchin RF
    Nanotoxicology; 2016 Sep; 10(7):981-91. PubMed ID: 27027807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specifically Formed Corona on Silica Nanoparticles Enhances Transforming Growth Factor β1 Activity in Triggering Lung Fibrosis.
    Wang Z; Wang C; Liu S; He W; Wang L; Gan J; Huang Z; Wang Z; Wei H; Zhang J; Dong L
    ACS Nano; 2017 Feb; 11(2):1659-1672. PubMed ID: 28085241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Recognition of Nanoparticle Protein Corona and Modified Low-Density Lipoprotein by Macrophage Receptor with Collagenous Structure.
    Lara S; Perez-Potti A; Herda LM; Adumeau L; Dawson KA; Yan Y
    ACS Nano; 2018 May; 12(5):4930-4937. PubMed ID: 29668255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.